Viewing Study NCT00079820


Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-01-01 @ 9:45 AM
Study NCT ID: NCT00079820
Status: COMPLETED
Last Update Posted: 2014-01-13
First Post: 2004-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Smallpox View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Smallpox View
None Smallpox Vaccine View
None Variola virus View
None Smallpox Virus View
None MODIFIED VACCINIA ANKARA View
None MVA View
None Dryvax View
None Dryvax vaccine View
None Protection against smallpox View